WINOOSKI VT, USA — BioTek Instruments, Inc., a leader in life science instrumentation, including advanced cell imaging systems, announced today that the United States Patent and Trademark Office has issued a patent to the Company for its “Autofocus for Imaging System” invention used in the Cytation and Lionheart FX products. The patented method uses a custom laser-based cube configuration, enabling quick and reproducible focusing of many sample types. Additionally, as the autofocus method requires less time and sample exposure to light compared to other focus methods, phototoxicity and photobleaching of sensitive samples is reduced.

This patented laser autofocus method is available in BioTek’s Cytation™ Cell Imaging Multi-Mode Readers, which combine automated digital microscopy and conventional multi-mode microplate detection for data-rich qualitative and quantitative data; and Lionheart™ FX Automated Microscope, a fully-integrated digital microscopy system with environmental control for a wide range of cell biology applications. Existing Cytation and Lionheart instruments may be easily upgraded with the laser autofocus capability via the addition of the custom cube and software.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations.